» Articles » PMID: 33087501

Mutations in ALS Cause Dysregulation of Calcium Homeostasis and Stress Granule Dynamics

Overview
Journal Sci Transl Med
Date 2020 Oct 22
PMID 33087501
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Dysregulation of calcium ion homeostasis and abnormal protein aggregation have been proposed as major pathogenic hallmarks underpinning selective degeneration of motor neurons in amyotrophic lateral sclerosis (ALS). Recently, mutations in annexin A11 (), a gene encoding a Ca-dependent phospholipid-binding protein, have been identified in familial and sporadic ALS. However, the physiological and pathophysiological roles of remain unknown. Here, we report functions of related to intracellular Ca homeostasis and stress granule dynamics. We analyzed the exome sequences of 500 Korean patients with sALS and identified nine variants in 13 patients. The amino-terminal variants p.G38R and p.D40G within the low-complexity domain of ANXA11 enhanced aggregation propensity, whereas the carboxyl-terminal ANX domain variants p.H390P and p.R456H altered Ca responses. Furthermore, all four variants in ANXA11 underwent abnormal phase separation to form droplets with aggregates and led to the alteration of the biophysical properties of ANXA11. These functional defects caused by ALS-linked variants induced alterations in both intracellular Ca homeostasis and stress granule disassembly. We also revealed that p.G228Lfs*29 reduced ANXA11 expression and impaired Ca homeostasis, as caused by missense variants. Ca-dependent interaction and coaggregation between ANXA11 and ALS-causative RNA-binding proteins, FUS and hnRNPA1, were observed in motor neuron cells and brain from a patient with ALS-FUS. The expression of ALS-linked variants in motor neuron cells caused cytoplasmic sequestration of endogenous FUS and triggered neuronal apoptosis. Together, our findings suggest that disease-associated mutations can contribute to ALS pathogenesis through toxic gain-of-function mechanisms involving abnormal protein aggregation.

Citing Articles

GWAS identifies genetic loci, lifestyle factors and circulating biomarkers that are risk factors for sarcoidosis.

Yuan S, Chen J, Geng J, Zhao S, Yarmolinsky J, Arkema E Nat Commun. 2025; 16(1):2481.

PMID: 40075078 PMC: 11903676. DOI: 10.1038/s41467-025-57829-z.


Semantic variant primary progressive aphasia with ANXA11 p.D40G.

Lee S, Yoon S, Park K, Kim A, Kim H, Jung N Alzheimers Dement. 2025; 21(3):e14566.

PMID: 40042459 PMC: 11881632. DOI: 10.1002/alz.14566.


Gain-of-function ANXA11 mutation cause late-onset ALS with aberrant protein aggregation, neuroinflammation and autophagy impairment.

Liu Q, Sun Y, He B, Chen H, Wang L, Wang G Acta Neuropathol Commun. 2025; 13(1):2.

PMID: 39755715 PMC: 11699697. DOI: 10.1186/s40478-024-01919-4.


Stress Granule Assembly in Pulmonary Arterial Hypertension.

Kosmas K, Papathanasiou A, Spyropoulos F, Rehman R, Cunha A, Fredenburgh L Cells. 2024; 13(21.

PMID: 39513903 PMC: 11544768. DOI: 10.3390/cells13211796.


Amyotrophic Lateral Sclerosis: Insights and New Prospects in Disease Pathophysiology, Biomarkers and Therapies.

Al-Khayri J, Ravindran M, Banadka A, Vandana C, Priya K, Nagella P Pharmaceuticals (Basel). 2024; 17(10).

PMID: 39459030 PMC: 11510162. DOI: 10.3390/ph17101391.